Kenneth Inchausti
Corporate Officer/Principal chez Novo Nordisk, Inc.
Profil
Kenneth Inchausti is currently the Director-Corporate Branding & Reputation at Novo Nordisk, Inc. Previously, he worked as the Head-Investor Relations & Communications at Ocugen, Inc. Mr. Inchausti completed his undergraduate degree at Old Dominion University.
Postes actifs de Kenneth Inchausti
| Sociétés | Poste | Début |
|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | 25/09/2014 |
Anciens postes connus de Kenneth Inchausti
| Sociétés | Poste | Fin |
|---|---|---|
| OCUGEN, INC. | Investor Relations Contact | 01/06/2022 |
Formation de Kenneth Inchausti
| Old Dominion University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
